Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Exercise program aims to steady the stance of osteoporosis patients

NCT ID NCT07763717

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 13, 2026 · Last updated Aug 14, 2026 · Updated 1 time

Summary

This trial tests whether a structured 12-week physiotherapy exercise program can improve balance, posture, and reduce fall risk in people with osteoporosis. Participants, aged 50 and older, will be randomly assigned to either the exercise program or a control group. The program focuses on balance, posture correction, and strength training, with the goal of enhancing stability and reducing the fear of falling.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A structured physiotherapy exercise program
What this could lead to
If effective, this program could offer a practical, drug-free way to improve balance and posture, potentially reducing falls and fractures in older adults with osteoporosis.
What could go wrong
This is a relatively small trial, and results may not apply to everyone. The program requires commitment, and benefits may vary depending on individual health and adherence.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 88 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Jun 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

50 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria:o Confirmed clinical diagnosis of osteoporosis, established through standard diagnostic procedures such as bone mineral density (BMD) assessment (e.g., T-score ≤ -2.5 at the lumbar spine, femoral neck, or total hip) or a physician's diagnosis based on clinical history and fracture risk assessment. * Aged 50 years or older. * Ability to understand and follow verbal and written instructions in Albanian. * Ability to ambulate independently, with or without an assistive device, for at least 10 meters. * Willingness to provide informed consent and commit to the full 12-week intervention period and follow-up assessments. Exclusion Criteria: * o Presence of any neurological disorder (e.g., Parkinson's disease, stroke) that significantly affects balance or mobility. * Acute fractures or recent (within the last 6 months) osteoporotic fractures that would preclude participation in an exercise program. * Severe cardiovascular or respiratory conditions that would contraindicate moderate-intensity exercise. * Uncontrolled systemic diseases (diabetes, hypertension). * Cognitive impairment that would interfere with understanding or adhering to the study protocol. * Participation in another balance or strength training program within the last 3 months. * Any other medical condition or medication use that, in the opinion of the primary investigator, would compromise participant safety or the integrity of the study results.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Osteoporosis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • University Clinical Center of Kosovo

    Pristina, 10050, Kosovo

More trials for these conditions

Other studies related to the condition(s) this trial covers.